ArticleEndocrine oncology (Bristol, England)2026

Cabergoline monotherapy in GH- and PRL-cosecreting pituitary adenomas.

James M McNeil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.